TPVG logo

TPVG

TriplePoint Venture Growth BDC Corp.NYSEFinancial Services
$5.09+3.88%ClosedMarket Cap: $206.1M

As of 2026-04-06

Valuation

View Details

P/E (TTM)

4.19

PEG

0.08

P/B

0.58

P/S

2.26

EV/EBITDA

8.65

DCF Value

$-11.23

FCF Yield

17.8%

Div Yield

19.8%

Margins & Returns

Gross Margin

89.0%

Operating Margin

61.2%

Net Margin

54.0%

ROE

14.0%

ROA

5.9%

ROIC

6.7%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$27.3M$8.1M$0.20
FY 2025$97.2M$49.2M$1.22
Q3 2025$22.2M$15.2M$0.38
Q2 2025$20.6M$13.2M$0.33

Analyst Ratings

View All
Wells FargoUnderweight
2026-03-05
Keefe, Bruyette & WoodsMarket Perform
2026-03-05
UBSNeutral
2025-10-14
Piper SandlerNeutral
2025-10-09
UBSNeutral
2025-07-16

Trading Activity

Insider Trades

View All
Labe Jamesdirector, officer: Chief Executive Officer
BuyTue Jan 13
Labe Jamesdirector, officer: Chief Executive Officer
BuyTue Jan 13
Srivastava Sajaldirector, officer: President and CIO
BuyTue Jan 13
Srivastava Sajaldirector, officer: President and CIO
BuyTue Jan 13
Srivastava Sajaldirector, officer: President and CIO
BuyFri Jan 09

Company Info

Sector

Financial Services

Industry

Country

US

Exchange

NYSE

Beta

1.38

TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.

Peers